CI
RDY icon

Corient IA’s Dr. Reddy's Laboratories RDY Stock Holding History

Corient IA’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79.7K Sell
5,500
-11,040
-67% -$149K 0.07% 233
2026
Q1 		$229K Hold
16,540
– – 0.22% 181
2025
Q4 		$232K Sell
16,540
-8,460
-34% -$119K 0.22% 185
2025
Q3 		$350K Hold
25,000
– – 0.26% 155
2025
Q2 		$376K Hold
25,000
– – 0.22% 181
2025
Q1 		$330K Buy
+25,000
New +$345K 0.23% 183

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Corient IA's RDY Position: Q2 2026 in Review

Corient IA reduced its Dr. Reddy's Laboratories (RDY) stake by 67% in Q2 2026, selling an estimated $149K and leaving 5,500 shares worth $79.7K. The position accounts for 0.07% of the portfolio, ranked #233.

Corient IA first reported a position in RDY in Q1 2025 and has held it in 6 quarters since. The position peaked at $376K in Q2 2025. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Corient IA held 5,500 shares of Dr. Reddy's Laboratories worth $79.7K as of Q2 2026.
  • Corient IA sold 11,040 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $149K.
  • Dr. Reddy's Laboratories made up 0.07% of Corient IA's portfolio in Q2 2026, its #233 holding.
  • Corient IA first reported a position in Dr. Reddy's Laboratories in Q1 2025 and has held it in 6 quarters since.
  • Corient IA's Dr. Reddy's Laboratories position peaked at $376K in Q2 2025.
  • 239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Corient IA's 13F filing for Q2 2026, filed 12 Aug 2026.